CN Stock MarketDetailed Quotes
000952 Hubei Guangji Pharmaceutical
- 5.50
- -0.21-3.68%
Trading Dec 25 10:34 CST
1.92BMarket Cap-8.30P/E (TTM)
5.80High5.48Low25.61KlotVolume5.74Open5.71Pre Close14.33MTurnover0.75%Turnover RatioLossP/E (Static)349.86MShares8.2952wk High1.60P/B1.89BFloat Cap4.1152wk Low6.28Limit Up343.99MShs Float42.70Historical High5.14Limit Down5.60%Amplitude0.72Historical Low--Dividend TTM5.59Avg Price14.56KlotAsk--Div YieldTTM100Lot Size10.82KlotBid
Hubei Guangji Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.54%462.19M | -13.80%296.46M | 56.27%180.16M | -7.50%737.82M | -2.57%522.49M | -8.54%343.91M | -13.49%115.29M | 1.54%797.64M | 12.59%536.28M | 16.30%376.02M |
| Operating revenue | -11.54%462.19M | -13.80%296.46M | 56.27%180.16M | -7.50%737.82M | -2.57%522.49M | -8.54%343.91M | -13.49%115.29M | 1.54%797.64M | 12.59%536.28M | 16.30%376.02M |
| Other operating revenue | ---- | 71.09%7.47M | ---- | 176.27%7.71M | ---- | 2,850.02%4.37M | ---- | 494.89%2.79M | ---- | -82.77%147.98K |
| Total operating cost | 6.24%628.44M | 9.95%404.57M | 49.09%239.27M | 15.00%862.66M | 11.88%591.55M | 2.42%367.96M | 19.43%160.48M | 6.34%750.16M | 26.16%528.71M | 26.37%359.25M |
| Operating cost | -4.30%355.86M | -6.68%222.07M | 59.92%150.66M | 6.58%535.62M | 6.19%371.86M | -5.46%237.97M | 4.36%94.21M | 3.76%502.53M | 24.92%350.19M | 24.87%251.71M |
| Operating tax surcharges | 1.33%10.07M | -2.72%6.69M | -13.02%3.54M | 1.39%13.69M | 0.14%9.94M | 1.16%6.87M | 18.84%4.07M | -15.45%13.5M | -16.66%9.93M | -18.35%6.79M |
| Operating expense | -2.20%28.39M | -13.08%19.41M | 6.88%10.44M | 15.03%38.64M | 24.84%29.03M | 37.71%22.33M | 106.17%9.76M | 10.87%33.59M | 49.22%23.25M | 72.96%16.21M |
| Administration expense | 44.13%150.5M | 66.78%103.07M | 62.31%50.22M | 34.24%156.19M | 21.67%104.42M | 25.02%61.8M | 40.02%30.94M | 8.74%116.35M | 20.10%85.82M | 23.52%49.43M |
| Financial expense | 42.22%38.91M | 110.27%24.91M | 64.06%8.32M | 187.73%43.77M | 244.53%27.36M | 104.81%11.85M | 8.67%5.07M | -3.64%15.21M | -26.67%7.94M | -9.86%5.79M |
| -Interest expense (Financial expense) | 38.06%44.08M | 90.48%29.15M | 68.45%9.34M | 132.93%49.15M | 124.88%31.93M | 62.52%15.31M | 16.67%5.54M | 26.29%21.1M | 21.75%14.2M | 38.15%9.42M |
| -Interest Income (Financial expense) | 32.67%-1.65M | 30.76%-1.05M | -11.52%-613.08K | -72.70%-3.46M | -78.39%-2.45M | -60.43%-1.51M | -29.12%-549.77K | 37.90%-2M | 39.05%-1.37M | 27.11%-943.52K |
| Research and development | -8.65%44.7M | 4.73%28.42M | -2.05%16.1M | 8.37%74.75M | -5.11%48.94M | -7.45%27.14M | 78.90%16.43M | 32.49%68.98M | 77.99%51.57M | 57.76%29.32M |
| Credit Impairment Loss | 111.76%392K | 84.70%-618.03K | -352.74%-1.25M | 99.38%-27.48K | 27.34%-3.33M | -25.44%-4.04M | 243.16%492.63K | -327.64%-4.45M | -206.87%-4.59M | -167.05%-3.22M |
| Asset Impairment Loss | -737.73%-14.76M | -570.96%-12.61M | -190.29%-741.26K | -85.55%-14.26M | 254.61%2.32M | 310.08%2.68M | 139.65%821.01K | -148.47%-7.69M | 114.11%652.85K | 123.72%652.85K |
| Other net revenue | 2.24%-4.27M | -101.12%-7.94M | 2,863.21%2.92M | -221.95%-16.22M | -140.99%-4.37M | -138.51%-3.95M | -101.08%-105.76K | -65.06%13.3M | -57.90%10.65M | -62.03%10.26M |
| Invest income | 47.87%-3.64M | 42.59%-2.92M | 71.36%-855.48K | -259.03%-10.02M | -241.43%-6.99M | -209.47%-5.09M | -150.83%-2.99M | -66.34%6.3M | -73.72%4.94M | -75.50%4.65M |
| -Including: Investment income associates | 69.70%-2.12M | 70.83%-1.49M | 71.36%-855.48K | -305.89%-8.93M | -266.08%-6.99M | -215.80%-5.09M | -147.99%-2.99M | -74.71%4.34M | -75.93%4.21M | -75.64%4.4M |
| Asset deal income | ---- | ---- | --84.38K | 105.88%253.34K | ---- | ---- | --0 | -891.92%-4.31M | ---- | ---- |
| Other revenue | 277.32%13.75M | 227.22%8.21M | 262.32%5.68M | -66.52%7.85M | -62.23%3.64M | -69.30%2.51M | -75.44%1.57M | 17.55%23.43M | 41.33%9.65M | 36.90%8.17M |
| Operating profit | -132.26%-170.52M | -314.56%-116.06M | -24.04%-56.19M | -332.07%-141.05M | -502.90%-73.42M | -203.61%-28M | -618.97%-45.3M | -48.58%60.78M | -77.92%18.22M | -59.08%27.02M |
| Add:Non operating Income | 20.68%1.11M | 8,019.56%1.06M | 350,685.78%1.07M | 33.21%1.2M | 1.99%916.89K | -97.15%13.06K | -99.85%306 | -86.20%899.42K | -6.89%898.98K | 9,059.77%457.99K |
| Less:Non operating expense | 121.48%1.59M | -96.02%25.68K | -82.38%91.67K | -49.22%811.45K | -50.85%717.04K | -48.23%645.47K | -57.59%520.16K | 322.34%1.6M | 460.81%1.46M | 2,798.16%1.25M |
| Total profit | -133.55%-171M | -301.79%-115.02M | -20.49%-55.2M | -334.12%-140.67M | -514.53%-73.22M | -209.14%-28.63M | -694.28%-45.82M | -51.68%60.08M | -78.78%17.66M | -60.25%26.23M |
| Less:Income tax cost | 202.36%1.46M | 207.72%540.49K | -27.45%-535.01K | -5.25%11.75M | -133.40%-1.42M | -116.76%-501.75K | -872.81%-419.79K | -33.09%12.4M | -104.89%-610.16K | -63.19%2.99M |
| Net profit | -140.21%-172.46M | -310.88%-115.56M | -20.42%-54.67M | -419.63%-152.41M | -492.90%-71.79M | -221.04%-28.13M | -693.01%-45.4M | -54.93%47.68M | -74.18%18.27M | -59.84%23.24M |
| Net profit from continuing operation | -140.21%-172.46M | -310.88%-115.56M | -20.42%-54.67M | -419.63%-152.41M | -492.90%-71.79M | -221.04%-28.13M | -693.01%-45.4M | -54.93%47.68M | -74.18%18.27M | -59.84%23.24M |
| Less:Minority Profit | -188.11%-13.88M | -284.21%-8.92M | -206.02%-4.16M | -359.16%-12.17M | -194.82%-4.82M | -59.13%-2.32M | -94.09%-1.36M | 38.37%-2.65M | 52.23%-1.63M | 21.73%-1.46M |
| Net profit of parent company owners | -136.76%-158.58M | -313.28%-106.65M | -14.69%-50.51M | -378.64%-140.25M | -436.44%-66.98M | -204.49%-25.8M | -627.02%-44.04M | -54.29%50.33M | -73.16%19.91M | -58.65%24.7M |
| Earning per share | ||||||||||
| Basic earning per share | -137.74%-0.4498 | -313.44%-0.3014 | -14.71%-0.1427 | -376.48%-0.3962 | -435.46%-0.1892 | -203.70%-0.0729 | -611.93%-0.1244 | -55.23%0.1433 | -73.84%0.0564 | -59.50%0.0703 |
| Diluted earning per share | -137.74%-0.4498 | -313.44%-0.3014 | -14.71%-0.1427 | -376.24%-0.3942 | -427.90%-0.1892 | -201.82%-0.0729 | -624.89%-0.1244 | -55.42%0.1427 | -73.24%0.0577 | -58.76%0.0716 |
| Other composite income | -125.70%-1.59K | -125.92%-4.5K | -265.79%-4.54K | 116.26%13.97K | 154.63%6.19K | 263.92%17.36K | 136.05%2.74K | 111.95%6.46K | 67.18%-11.33K | 52.85%-10.59K |
| Other composite income of parent company owners | -125.70%-1.59K | -125.92%-4.5K | -265.79%-4.54K | 116.26%13.97K | 154.63%6.19K | 263.92%17.36K | 136.05%2.74K | 111.95%6.46K | 67.18%-11.33K | 52.85%-10.59K |
| Total composite income | -140.23%-172.46M | -311.15%-115.57M | -20.44%-54.67M | -419.56%-152.4M | -493.11%-71.79M | -221.02%-28.11M | -693.56%-45.4M | -54.90%47.69M | -74.18%18.26M | -59.84%23.23M |
| Total composite income of parent company owners | -136.79%-158.58M | -313.58%-106.65M | -14.71%-50.51M | -378.57%-140.23M | -436.60%-66.97M | -204.46%-25.79M | -627.46%-44.04M | -54.26%50.34M | -73.17%19.9M | -58.65%24.69M |
| Total composite income of minority owners | -188.11%-13.88M | -284.21%-8.92M | -206.02%-4.16M | -359.16%-12.17M | -194.82%-4.82M | -59.13%-2.32M | -94.09%-1.36M | 38.37%-2.65M | 52.23%-1.63M | 21.73%-1.46M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
